Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE OF COMMON STOCK (Details Narrative)

v3.22.2.2
NET LOSS PER SHARE OF COMMON STOCK (Details Narrative) - shares
9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 11,094,104 10,303,626
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 300,000 860,000